{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T16:52:37Z","timestamp":1782492757164,"version":"3.54.5"},"reference-count":40,"publisher":"BMJ","issue":"3","license":[{"start":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T00:00:00Z","timestamp":1773014400000},"content-version":"unspecified","delay-in-days":8,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"Shuang-Ho Hospital, New Taipei, Taiwan and Taipei Medical University, Taipei, Taiwan","award":["112TMU-SHH-19"],"award-info":[{"award-number":["112TMU-SHH-19"]}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2026,2,17]]},"published-print":{"date-parts":[[2026,3]]},"abstract":"<jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>To investigate the association between longitudinal trajectories of metabolic risk clusters and the risk of progression to end-stage kidney disease (ESKD) and major adverse kidney events (MAKEs) in patients with chronic kidney disease (CKD).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design<\/jats:title>\n                    <jats:p>Prospective registry-based cohort study.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Setting<\/jats:title>\n                    <jats:p>Secondary and tertiary care settings in Taiwan, using data from a multidisciplinary pre-ESKD care programme.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Participants<\/jats:title>\n                    <jats:p>A total of 1494 adult patients with CKD stages 3b\u20135 enrolled in a structured pre-ESKD care programme.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Primary and secondary outcome measures<\/jats:title>\n                    <jats:p>Time to initiation of dialysis (primary outcome) and time to MAKE, defined as a composite of dialysis initiation or all-cause mortality (secondary outcome). Group-based multitrajectory modelling was used to categorise longitudinal trajectories of metabolic risk clusters, including systolic blood pressure, fasting blood glucose and low-density lipoprotein (LDL) cholesterol.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Four trajectory groups were identified: Group I had controlled blood pressure and glucose but elevated LDL (dialysis incidence: 19.5 per 1000 person-years); Group II had borderline-high blood pressure and elevated glucose (33.6 per 1000 person-years); Group III had controlled glucose and low LDL but borderline-high blood pressure (38.8 per 1000 person-years) and Group IV had controlled glucose but elevated blood pressure and LDL (46.7 per 1000 person-years). Compared with the other groups, Group I exhibited significantly longer dialysis-free and MAKE-free survival (log-rank test, p&lt;0.001). With covariates adjusted for, Groups II (HR 1.02, 95%\u2009CI 0.52 to 2.00) and III (HR 1.46, 95%\u2009CI 0.85 to 2.52) showed non-significant elevations in dialysis risk, whereas Group IV (HR 1.96, 95%\u2009CI 1.01 to 3.78) exhibited a significantly higher risk compared with Group I. Similar patterns were observed for MAKE outcome, confirming the association between trajectory groups and adverse kidney events.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Longitudinal trajectories of metabolic risk cluster are associated with differential risks of CKD progression to ESKD and death. Our findings provide valuable insights into the monitoring of metabolic risk profiles over time in patients with CKD.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjopen-2025-110041","type":"journal-article","created":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T14:25:30Z","timestamp":1773066330000},"page":"e110041","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":0,"title":["Trajectories of metabolic risk clusters and adverse outcomes in patients with chronic kidney disease: a prospective cohort study in Taiwan"],"prefix":"10.1136","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4818-8263","authenticated-orcid":false,"given":"Wei-Cheng","family":"Lo","sequence":"first","affiliation":[{"name":"Master Program in Applied Epidemiology, College of Public Health, Taipei Medical University, Taipei, Taiwan"},{"name":"School of Public Health, College of Public Health, Taipei Medical University, Taipei, Taiwan"},{"name":"TMU Research Center of Urology and Kidney, Taipei Medical University, Taipei, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mei-Yi","family":"Wu","sequence":"additional","affiliation":[{"name":"TMU Research Center of Urology and Kidney, Taipei Medical University, Taipei, Taiwan"},{"name":"Division of Nephrology, Department of Internal Medicine, Shuang Ho Hospital, Taipei Medical University, New Taipei City, Taiwan"},{"name":"Division of Nephrology, Department of Internal Medicine, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Hsuan Roger","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Environmental Health and Engineering, Johns Hopkins University, Baltimore, Maryland, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mai Szu","family":"Wu","sequence":"additional","affiliation":[{"name":"TMU Research Center of Urology and Kidney, Taipei Medical University, Taipei, Taiwan"},{"name":"Division of Nephrology, Department of Internal Medicine, Shuang Ho Hospital, Taipei Medical University, New Taipei City, Taiwan"},{"name":"Division of Nephrology, Department of Internal Medicine, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chung\u2011Shun","family":"Wong","sequence":"additional","affiliation":[{"name":"Division of Emergency Medicine, Department of Emergency and Critical Care, Shuang Ho Hospital, Taipei Medical University, New Taipei City, Taiwan"},{"name":"Department of Emergency Medicine, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2026,3,9]]},"reference":[{"key":"2026062609355105000_16.3.e110041.1","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0158765","article-title":"Global Prevalence of Chronic Kidney Disease - A Systematic Review and Meta-Analysis","volume":"11","author":"Hill","year":"2016","journal-title":"PLoS One"},{"key":"2026062609355105000_16.3.e110041.2","doi-asserted-by":"publisher","DOI":"10.1038\/nrneph.2015.173"},{"key":"2026062609355105000_16.3.e110041.3","doi-asserted-by":"crossref","DOI":"10.1186\/s12882-018-0991-5","article-title":"Sociodemographic associations with abnormal estimated glomerular filtration rate (eGFR) in a large Canadian city: a cross-sectional observation study","volume":"19","author":"Ma","year":"2018","journal-title":"BMC Nephrol"},{"key":"2026062609355105000_16.3.e110041.4","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2005101085"},{"key":"2026062609355105000_16.3.e110041.5","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(13)60595-4"},{"key":"2026062609355105000_16.3.e110041.6","first-page":"2918","article-title":"Cardiovascular disease and its relationship with chronic kidney disease","volume":"18","author":"Liu","year":"2014","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"2026062609355105000_16.3.e110041.7","doi-asserted-by":"publisher","DOI":"10.1037\/1082-989X.4.2.139"},{"key":"2026062609355105000_16.3.e110041.8","doi-asserted-by":"publisher","DOI":"10.1159\/000360229"},{"key":"2026062609355105000_16.3.e110041.9","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.clinpsy.121208.131413"},{"key":"2026062609355105000_16.3.e110041.10","doi-asserted-by":"publisher","DOI":"10.1177\/0962280216673085"},{"key":"2026062609355105000_16.3.e110041.11","doi-asserted-by":"publisher","DOI":"10.1016\/j.jfma.2013.10.021"},{"key":"2026062609355105000_16.3.e110041.12","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2006.03.051"},{"key":"2026062609355105000_16.3.e110041.13","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-150-9-200905050-00006"},{"key":"2026062609355105000_16.3.e110041.14","doi-asserted-by":"publisher","DOI":"10.1038\/sj.ki.5000050"},{"key":"2026062609355105000_16.3.e110041.15","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1093\/joneph\/21.3.305","article-title":"Metabolic syndrome and chronic kidney disease: a Japanese perspective on a worldwide problem","volume":"21","author":"Iseki","year":"2008","journal-title":"J Nephrol"},{"key":"2026062609355105000_16.3.e110041.16","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1007\/s00380-012-0254-5","article-title":"Metabolic syndrome and risk of progression of chronic kidney disease: a single-center cohort study in Japan","volume":"28","author":"Saito","year":"2013","journal-title":"Heart Vessels"},{"key":"2026062609355105000_16.3.e110041.17","doi-asserted-by":"crossref","first-page":"198","DOI":"10.3109\/0886022X.2015.1117904","article-title":"Prevalence and determinants of the metabolic syndrome among subjects with advanced nondiabetes-related chronic kidney disease in Gran Canaria, Spain","volume":"38","author":"Boronat","year":"2016","journal-title":"Ren Fail"},{"key":"2026062609355105000_16.3.e110041.18","doi-asserted-by":"publisher","DOI":"10.1136\/jech-2014-205160"},{"key":"2026062609355105000_16.3.e110041.19","doi-asserted-by":"publisher","DOI":"10.1291\/hypres.30.937"},{"key":"2026062609355105000_16.3.e110041.20","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2005010106"},{"key":"2026062609355105000_16.3.e110041.21","doi-asserted-by":"publisher","DOI":"10.1053\/ajkd.2003.50120"},{"key":"2026062609355105000_16.3.e110041.22","doi-asserted-by":"publisher","DOI":"10.1053\/j.ackd.2005.07.011"},{"key":"2026062609355105000_16.3.e110041.23","first-page":"582","article-title":"Cross-sectional study on high-normal blood pressure and chronic kidney disease in occupational physical examination population in Changsha","volume":"39","author":"Cao","year":"2014","journal-title":"Zhong Nan Da Xue Xue Bao Yi Xue Ban"},{"key":"2026062609355105000_16.3.e110041.24","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-139-4-200308190-00006"},{"key":"2026062609355105000_16.3.e110041.25","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2005.06.014"},{"key":"2026062609355105000_16.3.e110041.26","doi-asserted-by":"publisher","DOI":"10.1038\/ki.1992.126"},{"key":"2026062609355105000_16.3.e110041.27","doi-asserted-by":"crossref","DOI":"10.3390\/ijerph17010300","article-title":"Laboratory Parameters of Hemostasis, Adhesion Molecules, and Inflammation in Type 2 Diabetes Mellitus: Correlation with Glycemic Control","volume":"17","author":"Palella","year":"2020","journal-title":"Int J Environ Res Public Health"},{"key":"2026062609355105000_16.3.e110041.28","doi-asserted-by":"crossref","DOI":"10.1186\/s12933-018-0762-4","article-title":"Association between insulin resistance and the development of cardiovascular disease","volume":"17","author":"Ormazabal","year":"2018","journal-title":"Cardiovasc Diabetol"},{"key":"2026062609355105000_16.3.e110041.29","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0274605","article-title":"Association of poorly controlled HbA1c with increased risk of progression to end-stage kidney disease and all-cause mortality in patients with diabetes and chronic kidney disease","volume":"17","author":"Chen","year":"2022","journal-title":"PLoS One"},{"key":"2026062609355105000_16.3.e110041.30","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1053\/j.ajkd.2016.11.018","article-title":"Diabetes Control and the Risks of ESRD and Mortality in Patients With CKD","volume":"70","author":"Navaneethan","year":"2017","journal-title":"Am J Kidney Dis"},{"key":"2026062609355105000_16.3.e110041.31","doi-asserted-by":"publisher","DOI":"10.2337\/dc15-2322"},{"key":"2026062609355105000_16.3.e110041.32","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2015-010401","article-title":"Lack of an association or an inverse association between low-density-lipoprotein cholesterol and mortality in the elderly: a systematic review","volume":"6","author":"Ravnskov","year":"2016","journal-title":"BMJ Open"},{"key":"2026062609355105000_16.3.e110041.33","doi-asserted-by":"publisher","DOI":"10.1194\/jlr.P084590"},{"key":"2026062609355105000_16.3.e110041.34","first-page":"1","article-title":"Towards a Paradigm Shift in Cholesterol Treatment. A Re-examination of the Cholesterol Issue in Japan","volume":"66 Suppl 4","author":"Hamazaki","year":"2015","journal-title":"Ann Nutr Metab"},{"key":"2026062609355105000_16.3.e110041.35","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.09320913"},{"key":"2026062609355105000_16.3.e110041.36","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.09870912"},{"key":"2026062609355105000_16.3.e110041.37","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2008.01.013"},{"key":"2026062609355105000_16.3.e110041.38","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1111\/joim.13355","article-title":"Association of the metabolic syndrome with mortality and major adverse cardiac events: A large chronic kidney disease cohort","volume":"290","author":"Pammer","year":"2021","journal-title":"J Intern Med"},{"key":"2026062609355105000_16.3.e110041.39","doi-asserted-by":"crossref","DOI":"10.1002\/dmrr.3618","article-title":"High risk of renal outcome of metabolic syndrome independent of diabetes in patients with CKD stage 1-4: The ICKD database","volume":"39","author":"Lin","year":"2023","journal-title":"Diabetes Metab Res Rev"},{"key":"2026062609355105000_16.3.e110041.40","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2013070754"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2025-110041","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T16:38:09Z","timestamp":1782491889000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2025-110041"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":40,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2026,3,9]]},"published-print":{"date-parts":[[2026,3]]}},"alternative-id":["10.1136\/bmjopen-2025-110041"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2025-110041","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3]]}}}